1. Academic Validation
  2. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names

  • MAbs. 2022 Jan-Dec;14(1):2123299. doi: 10.1080/19420862.2022.2123299.
Ian Wilkinson 1 Geoff Hale 1
Affiliations

Affiliation

  • 1 mAbsolve Limited, Oxford, UK.
Abstract

By combining and cross-checking data from the World Health Organization's lists of international nonproprietary names with three other databases, we assembled a dataset of amino acid sequences of 819 antibody-related therapeutics. This enabled the systematic tabulation of 57 different molecular formats and about 90 different constant-region variants (47 for silencing, 14 for enhancement, 8 for modifying binding to FcRn, 13 for heterodimerization, 4 for site-specific modification and 4 for stabilization), as well as the frequencies of different targets and immunoglobulin allotypes. The curated dataset provides a resource for researchers, giving insights into trends in antibody engineering and a guide to the most frequently tested designs.

Keywords

Allotype; FC receptor; FC region; immunoglobulin fusion protein; immunoglobulin sequence; international nonproprietary name; therapeutic antibody.

Figures
Products